1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. PPAR
  4. PPARα Inhibitors

PPARα Inhibitors

PPARα

PPARβ/δ

PPARγ

PPAR

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform PPARα together.

Please try each isoform separately.

PPARα Specific Agonists, Antagonists, Activators & Modulators
Product Name PPARα PPARβ/δ PPARγ PPARα Selectivity Purity
CUDA
PPARα
    Selective Activator >98.0%
GW 6471
PPARα
    Selective Antagonist 98.98%
Fenofibrate
PPARα, IC50: 30 μM
    Selective Agonist 99.92%
Icariin
PPARα
    Selective Activator 98.75%
Pirinixic acid
PPARα, EC50: 0.63 μM
 
PPARγ, EC50: 32 μM
Selective Agonist 99.48%
GW7647
PPARα, EC50: 6 nM (Human PPARα)
PPARδ, EC50: 6.2 μM (Human PPARδ)
PPARγ, EC50: 1.1 μM (Human PPARγ)
Selective Agonist 98.04%
Saroglitazar
PPARα, EC50: 0.65 pM (HepG2 cell)
 
PPARγ, EC50: 3 nM (HepG2 cell)
Selective Agonist 98.03%
Palmitelaidic Acid
PPARα
    Selective Activator >99.0%
Saroglitazar Magnesium
PPARα, EC50: 0.65 pM (HepG2 cell)
 
PPARγ, EC50: 3 nM (HepG2 cell)
Selective Agonist 98.85%
NXT629
hPPARα, IC50: 77 nM
hPPARδ, IC50: 6 μM
hPPARγ, IC50: 15 μM
Selective Antagonist 99.05%
Gemfibrozil
PPAR-α
    Selective Activator 99.91%
Eupatilin
PPARα
    Selective Agonist 99.01%
Oleoylethanolamide
PPAR-α
    Selective Agonist 99.55%
Ciprofibrate
PPARα
    Selective Agonist 99.79%
BMS-687453
PPARα, IC50: 260 nM (Human PPARα)
    Selective Agonist 99.04%
Gypenoside XLIX
PPAR-α
    Selective Activator >99.0%
AVE-8134
PPARα, EC50: 100 nM (Human PPARα)
    Selective Agonist
PPARα-MO-1
PPARα
    Selective Modulator
Retinoic acid
PPARα, Kd: 103 nM
PPARβ/δ, Kd: 17 nM
PPARγ, Kd: 178 nM
Pan Agonist 99.74%
GW9662
PPARα, IC50: 32 nM
PPARδ, IC50: 2000 nM
PPARγ, IC50: 3.3 nM
Pan Antagonist 99.83%
Elafibranor
PPAR-α, EC50: 45 nM
PPAR-δ, EC50: 175 nM
  Pan Agonist 99.18%
T0070907
PPARα, Ki: 0.85 μM
PPARδ, Ki: 1.8 μM
PPARγ, Ki: 1 nM
Pan Antagonist 99.34%
Pioglitazone
hPPARα, EC50: 100 μM
mouse PPARα, EC50: 100 μM
hPPARδ, EC50: 43 μM
hPPARγ, EC50: 0.93 μM
mouse PPARγ, EC50: 0.99 μM
Pan Activator 99.18%
Pioglitazone hydrochloride
PPARα, EC50: 0.93 μM (Human PPARα)
PPARδ, EC50: 0.01 μM (Human PPARδ)
PPARγ, EC50: 43 μM (Human PPARγ)
Pan Agonist 96.39%
CDDO-Im
PPARα, Ki: 232 nM
 
PPARγ, Ki: 344 nM
Pan Activator 98.20%
GW0742
PPARα, EC50: 1.1 μM
PPARδ, EC50: 1 nM
PPARγ, EC50: 2 μM
Pan Agonist 97.27%
Daidzein
PPAR-α
 
PPAR-γ
Pan Activator 99.66%
Bezafibrate
hPPARα, EC50: 50 μM
hPPARδ, EC50: 20 μM
hPPARγ, EC50: 60 μM
Pan Agonist 99.43%
Lanifibranor
PPARα, EC50: 1537 nM (Human PPARα)
PPARδ, EC50: 866 nM (Human PPARδ)
PPARγ, EC50: 206 nM (Human PPARγ)
Pan Agonist 98.89%
Clofibrate
PPARα, EC50: 50 μM
 
PPARγ, EC50: 500 μM
Pan Agonist 99.59%
Fenofibric acid
PPARα, EC50: 22.4 μM
PPARδ, EC50: 1.06 μM
PPARγ, EC50: 1.47 μM
Pan Agonist 99.67%
Raspberry ketone
PPAR-α
    Pan Agonist 99.91%
Indeglitazar
PPARα
PPARδ
PPARγ
Pan Agonist 99.42%
Aleglitazar
PPARα, IC50: 38 nM
 
PPARγ, IC50: 19 nM
Pan Agonist 99.30%
Seladelpar
PPAR-α, EC50: 1600 nM
PPAR-δ, EC50: 2 nM
  Pan Agonist
LJ570
PPARα, EC50: 1.05 μM
 
PPARγ, EC50: 0.12 μM
Pan Agonist
Ophiopogonin D
PPARα
    Pan Activator
Chiglitazar
PPARα, EC50: 1.8 μM
PPARδ, EC50: 1.7 μM
PPARγ, EC50: 0.08 μM
Pan Agonist
Ertiprotafib
PPARα, EC50: ~1 μM
PPARβ, EC50: ~1 μM
  Pan Agonist
13-Oxo-9E,11E-octadecadienoic acid
PPARα
    Pan Activator
Bilobetin
PPARα
    Pan Activator
Imiglitazar
PPARα, EC50: 67 nM
 
PPARγ1, EC50: 31 nM
Pan Agonist
PPAR agonist 1
PPARα
 
PPARγ
Pan Agonist